ResearcherJilin UniversityActive in the last 2 years

Xingyu Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-3815-4953; OpenAlex author ID A5100435055. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion. Co-author DOI 10.1038/s41419-025-08155-1 ↗
Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer via the Wnt/β-catenin pathway Co-author DOI 10.21203/rs.3.rs-1976828/v1 ↗
Histone methylation in pancreatic cancer and its clinical implications. Co-author DOI 10.3748/wjg.v27.i36.6004 ↗
A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospective study. Co-author DOI 10.7150/jca.61101 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sheng Yan · 2 shared papers, 2021–2025 · strength 0.38
- Paper IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cance… DOI 10.1038/s41419-025-08155-1 ↗
- Paper A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospecti… DOI 10.7150/jca.61101 ↗
Hengqing Zhu · 1 shared paper, 2025 · strength 0.22
- Paper IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cance… DOI 10.1038/s41419-025-08155-1 ↗
Long Liu · 1 shared paper, 2025 · strength 0.22
- Paper IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cance… DOI 10.1038/s41419-025-08155-1 ↗
Xiaoyuan Liang · 1 shared paper, 2021 · strength 0.16
- Paper A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospecti… DOI 10.7150/jca.61101 ↗
Ying Wang · 1 shared paper, 2021 · strength 0.15
- Paper Histone methylation in pancreatic cancer and its clinical implications. DOI 10.3748/wjg.v27.i36.6004 ↗
Lisha Li · 1 shared paper, 2021 · strength 0.15
- Paper Histone methylation in pancreatic cancer and its clinical implications. DOI 10.3748/wjg.v27.i36.6004 ↗
Guangnian Zhang · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Xiaobin Huang · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Jianshui Li · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Dawei Deng · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Chuan Lan · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Jun Yu · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.